Tanja Meyer, based in San Francisco, CA, US, is currently a VP and Head, Corporate Strategy and Business Development at Ambagon Therapeutics, bringing experience from previous roles at Metagenomi, Allogene Therapeutics, BioMarin Pharmaceutical Inc. and Sangamo Therapeutics, Inc.. Tanja Meyer holds a 2004 - 2008 Doctor of Philosophy (Ph.D.) in Molecular Medicine @ UCSF / University of Erlangen-Nuremberg. With a robust skill set that includes Cell, Science, R&d, Life Sciences and more, Tanja Meyer contributes valuable insights to the industry. Tanja Meyer has 2 emails on RocketReach.